Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1993 Jun;35(6):565–574. doi: 10.1111/j.1365-2125.1993.tb04182.x

Diagnosis and treatment of human hydatidosis.

H Wen 1, R R New 1, P S Craig 1
PMCID: PMC1381596  PMID: 8329280

Full text

PDF
565

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alltree M. Scanning in hydatid disease. Clin Radiol. 1979 Nov;30(6):691–697. doi: 10.1016/s0009-9260(79)80022-7. [DOI] [PubMed] [Google Scholar]
  2. Ammann R. W., Hirsbrunner R., Cotting J., Steiger U., Jacquier P., Eckert J. Recurrence rate after discontinuation of long-term mebendazole therapy in alveolar echinococcosis (preliminary results). Am J Trop Med Hyg. 1990 Nov;43(5):506–515. doi: 10.4269/ajtmh.1990.43.506. [DOI] [PubMed] [Google Scholar]
  3. Ammann R., Tschudi K., von Ziegler M., Meister F., Cotting J., Eckert J., Witassek F., Freiburghaus A. Langzeitverlauf bei 60 Patienten mit alveolärer Echinokokkose unter Dauertherapie mit Mebendazol (1976-85). Klin Wochenschr. 1988 Nov 1;66(21):1060–1073. doi: 10.1007/BF01711918. [DOI] [PubMed] [Google Scholar]
  4. Bekhti A., Pirotte J. Cimetidine increases serum mebendazole concentrations. Implications for treatment of hepatic hydatid cysts. Br J Clin Pharmacol. 1987 Sep;24(3):390–392. doi: 10.1111/j.1365-2125.1987.tb03186.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bekhti A., Schaaps J. P., Capron M., Dessaint J. P., Santoro F., Capron A. Treatment of hepatic hydatid disease with mebedazole: preliminary results in four cases. Br Med J. 1977 Oct 22;2(6094):1047–1051. doi: 10.1136/bmj.2.6094.1047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bresson-Hadni S., Franza A., Miguet J. P., Vuitton D. A., Lenys D., Monnet E., Landecy G., Paintaud G., Rohmer P., Becker M. C. Orthotopic liver transplantation for incurable alveolar echinococcosis of the liver: report of 17 cases. Hepatology. 1991 Jun;13(6):1061–1070. [PubMed] [Google Scholar]
  7. Bryceson A. D., Woestenborghs R., Michiels M., van den Bossche H. Bioavailability and tolerability of mebendazole in patients with inoperable hydatid disease. Trans R Soc Trop Med Hyg. 1982;76(4):563–564. doi: 10.1016/0035-9203(82)90163-8. [DOI] [PubMed] [Google Scholar]
  8. Chi P., Zhang W., Zhang Z., Hasyet M., Liu F., Ding Z., Andersen F. L., Tolley H. D., Schantz P. M. Cystic echinococcosis in the Xinjiang/Uygur Autonomous Region, People's Republic of China. I. Demographic and epidemiologic data. Trop Med Parasitol. 1990 Jun;41(2):157–162. [PubMed] [Google Scholar]
  9. Chinnery J. B., Morris D. L. Effect of albendazole sulphoxide on viability of hydatid protoscoleces in vitro. Trans R Soc Trop Med Hyg. 1986;80(5):815–817. doi: 10.1016/0035-9203(86)90392-5. [DOI] [PubMed] [Google Scholar]
  10. Condon J., Rausch R. L., Wilson J. F. Application of the avidin-biotin immunohistochemical method for the diagnosis of alveolar hydatid disease from tissue sections. Trans R Soc Trop Med Hyg. 1988;82(5):731–735. doi: 10.1016/0035-9203(88)90219-2. [DOI] [PubMed] [Google Scholar]
  11. Craig P. S., Deshan L., MacPherson C. N., Dazhong S., Reynolds D., Barnish G., Gottstein B., Zhirong W. A large focus of alveolar echinococcosis in central China. Lancet. 1992 Oct 3;340(8823):826–831. doi: 10.1016/0140-6736(92)92693-a. [DOI] [PubMed] [Google Scholar]
  12. Craig P. S. Detection of specific circulating antigen, immune complexes and antibodies in human hydatidosis from Turkana (Kenya) and Great Britain, by enzyme-immunoassay. Parasite Immunol. 1986 Mar;8(2):171–188. doi: 10.1111/j.1365-3024.1986.tb00843.x. [DOI] [PubMed] [Google Scholar]
  13. Craig P. S., Liu D., Deshan L., Ding Z., Zhaoxun D. Hydatid disease in China. Parasitol Today. 1991 Feb;7(2):46–50. doi: 10.1016/0169-4758(91)90188-t. [DOI] [PubMed] [Google Scholar]
  14. D'Alessandro A., Rausch R. L., Cuello C., Aristizabal N. Echinococcus vogeli in man, with a review of polycystic hydatid disease in Colombia and neighboring countries. Am J Trop Med Hyg. 1979 Mar;28(2):303–317. doi: 10.4269/ajtmh.1979.28.303. [DOI] [PubMed] [Google Scholar]
  15. Davis A., Pawlowski Z. S., Dixon H. Multicentre clinical trials of benzimidazolecarbamates in human echinococcosis. Bull World Health Organ. 1986;64(3):383–388. [PMC free article] [PubMed] [Google Scholar]
  16. Didier D., Weiler S., Rohmer P., Lassegue A., Deschamps J. P., Vuitton D., Miguet J. P., Weill F. Hepatic alveolar echinococcosis: correlative US and CT study. Radiology. 1985 Jan;154(1):179–186. doi: 10.1148/radiology.154.1.3880602. [DOI] [PubMed] [Google Scholar]
  17. Filice C., Di Perri G., Strosselli M., Pirola F., Brunetti E., Dughetti S., Concia E. Parasitologic findings in percutaneous drainage of human hydatid liver cysts. J Infect Dis. 1990 Jun;161(6):1290–1295. doi: 10.1093/infdis/161.6.1290. [DOI] [PubMed] [Google Scholar]
  18. French C. M. Mebendazole and surgery for human hydatid disease in Turkana. East Afr Med J. 1984 Feb;61(2):113–119. [PubMed] [Google Scholar]
  19. Gargouri M., Ben Amor N., Ben Chehida F., Hammou A., Gharbi H. A., Ben Cheikh M., Kchouk H., Ayachi K., Golvan J. Y. Percutaneous treatment of hydatid cysts (Echinococcus granulosus). Cardiovasc Intervent Radiol. 1990 Jun-Jul;13(3):169–173. doi: 10.1007/BF02575469. [DOI] [PubMed] [Google Scholar]
  20. Gemmell M. A., Lawson J. R., Roberts M. G. Towards global control of cystic and alveolar hydatid diseases. Parasitol Today. 1987 May;3(5):144–151. doi: 10.1016/0169-4758(87)90198-0. [DOI] [PubMed] [Google Scholar]
  21. Gottstein B., Eckert J., Fey H. Serological differentiation between Echinococcus granulosus and E. multilocularis infections in man. Z Parasitenkd. 1983;69(3):347–356. doi: 10.1007/BF00927876. [DOI] [PubMed] [Google Scholar]
  22. Gottstein B., Mesarina B., Tanner I., Ammann R. W., Wilson J. F., Eckert J., Lanier A. Specific cellular and humoral immune responses in patients with different long-term courses of alveolar echinococcosis (infection with Echinococcus multilocularis). Am J Trop Med Hyg. 1991 Dec;45(6):734–742. doi: 10.4269/ajtmh.1991.45.734. [DOI] [PubMed] [Google Scholar]
  23. Horton R. J. Chemotherapy of Echinococcus infection in man with albendazole. Trans R Soc Trop Med Hyg. 1989 Jan-Feb;83(1):97–102. doi: 10.1016/0035-9203(89)90724-4. [DOI] [PubMed] [Google Scholar]
  24. Jiang C. [Second review of current status in epidemiology of hydatid cyst in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 1991 Apr;12(2):124–127. [PubMed] [Google Scholar]
  25. Kammerer W. S., Schantz P. M. Long term follow-up of human hydatid disease (Echinococcus granulosus) treated with a high-dose mebendazole regimen. Am J Trop Med Hyg. 1984 Jan;33(1):132–137. doi: 10.4269/ajtmh.1984.33.132. [DOI] [PubMed] [Google Scholar]
  26. Lacey E., Brady R. L., Prichard R. K., Watson T. R. Comparison of inhibition of polymerisation of mammalian tubulin and helminth ovicidal activity by benzimidazole carbamates. Vet Parasitol. 1987 Jan;23(1-2):105–119. doi: 10.1016/0304-4017(87)90029-x. [DOI] [PubMed] [Google Scholar]
  27. Lacey E. Mode of action of benzimidazoles. Parasitol Today. 1990 Apr;6(4):112–115. doi: 10.1016/0169-4758(90)90227-u. [DOI] [PubMed] [Google Scholar]
  28. Luder P. J., Siffert B., Witassek F., Meister F., Bircher J. Treatment of hydatid disease with high oral doses of mebendazole. Long-term follow-up of plasma mebendazole levels and drug interactions. Eur J Clin Pharmacol. 1986;31(4):443–448. doi: 10.1007/BF00613522. [DOI] [PubMed] [Google Scholar]
  29. MacPherson C. N., Romig T., Zeyhle E., Rees P. H., Were J. B. Portable ultrasound scanner versus serology in screening for hydatid cysts in a nomadic population. Lancet. 1987 Aug 1;2(8553):259–261. doi: 10.1016/s0140-6736(87)90839-7. [DOI] [PubMed] [Google Scholar]
  30. Matossian R. M., Awar G. N., Radwan H., Craig P. S., Meshefedjian G. A. Immune status during albendazole therapy for hydatidosis. Ann Trop Med Parasitol. 1992 Feb;86(1):67–75. doi: 10.1080/00034983.1992.11812632. [DOI] [PubMed] [Google Scholar]
  31. Matossian R. M., Rickard M. D., Smyth J. D. Hydatidosis: a global problem of increasing importance. Bull World Health Organ. 1977;55(4):499–507. [PMC free article] [PubMed] [Google Scholar]
  32. Meneghelli U. G., Martinelli A. L., Bellucci A. D., Villanova M. G., Velludo M. A., Magro J. E. Polycystic hydatid disease (Echinococcus vogeli). Treatment with albendazole. Ann Trop Med Parasitol. 1992 Apr;86(2):151–156. doi: 10.1080/00034983.1992.11812645. [DOI] [PubMed] [Google Scholar]
  33. Morris D. L., Dykes P. W., Marriner S., Bogan J., Burrows F., Skeene-Smith H., Clarkson M. J. Albendazole--objective evidence of response in human hydatid disease. JAMA. 1985 Apr 12;253(14):2053–2057. doi: 10.1001/jama.253.14.2053. [DOI] [PubMed] [Google Scholar]
  34. Morris D. L., Gould S. E. Serum and cyst concentrations of mebendazole and flubendazole in hydatid disease. Br Med J (Clin Res Ed) 1982 Jul 17;285(6336):175–175. doi: 10.1136/bmj.285.6336.175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Morris D. L., Skene-Smith H., Haynes A., Burrows F. G. Abdominal hydatid disease: computed tomographic and ultrasound changes during albendazole therapy. Clin Radiol. 1984 Jul;35(4):297–300. doi: 10.1016/s0009-9260(84)80099-9. [DOI] [PubMed] [Google Scholar]
  36. Morris D. L., Smith P. G. Albendazole in hydatid disease--hepatocellular toxicity. Trans R Soc Trop Med Hyg. 1987;81(2):343–344. doi: 10.1016/0035-9203(87)90259-8. [DOI] [PubMed] [Google Scholar]
  37. Morris D. L., Taylor D. H., Daniels D., Riley E. M., Richards K. S. Determination of the minimum time of praziquantel therapy required for the in vitro treatment of protoscoleces of Echinococcus granulosus. J Helminthol. 1988 Mar;62(1):10–14. doi: 10.1017/s0022149x00011135. [DOI] [PubMed] [Google Scholar]
  38. Morris D. L., Taylor D., Daniels D., Richards K. S. Determination of minimum effective concentration of praziquantel in in vitro cultures of protoscoleces of Echinococcus granulosus. Trans R Soc Trop Med Hyg. 1987;81(3):494–497. doi: 10.1016/0035-9203(87)90173-8. [DOI] [PubMed] [Google Scholar]
  39. Niron E. A., Ozer H. Ultrasound appearances of liver hydatid disease. Br J Radiol. 1981 Apr;54(640):335–338. doi: 10.1259/0007-1285-54-640-335. [DOI] [PubMed] [Google Scholar]
  40. Pan H. L., Cole C. A., Fletcher T. L. New compounds: derivatives of fluorene XXXVII: 9-substituted 3-nitrofluorenes. J Pharm Sci. 1980 Jan;69(1):122–123. doi: 10.1002/jps.2600690141. [DOI] [PubMed] [Google Scholar]
  41. RAUSCH R., SCHILLER E. L. Hydatid disease (Echinococcosis) in Alaska and the importance of rodent intermediate hosts. Science. 1951 Jan 19;113(2925):57–58. doi: 10.1126/science.113.2925.57. [DOI] [PubMed] [Google Scholar]
  42. Richards K. S., Morris D. L., Daniels D., Riley E. M. Echinococcus granulosus: the effects of praziquantel, in vivo and in vitro, on the ultrastructure of equine strain murine cysts. Parasitology. 1988 Apr;96(Pt 2):323–336. doi: 10.1017/s0031182000058327. [DOI] [PubMed] [Google Scholar]
  43. Russell G. J., Lacey E. Temperature dependent binding of mebendazole to tubulin in benzimidazole-susceptible and -resistant strains of Trichostrongylus colubriformis and Caenorhabditis elegans. Int J Parasitol. 1991 Dec;21(8):927–934. doi: 10.1016/0020-7519(91)90168-7. [DOI] [PubMed] [Google Scholar]
  44. Saimot A. G., Meulemans A., Cremieux A. C., Giovanangeli M. D., Hay J. M., Delaitre B., Coulaud J. P. Albendazole as a potential treatment for human hydatidosis. Lancet. 1983 Sep 17;2(8351):652–656. doi: 10.1016/s0140-6736(83)92533-3. [DOI] [PubMed] [Google Scholar]
  45. Schantz P. M. Hidatidosis: magnitud del problema y perspectivas de control. Bol Oficina Sanit Panam. 1972 Sep;73(3):187–197. [PubMed] [Google Scholar]
  46. Schantz P. M., Van den Bossche H., Eckert J. Chemotherapy for larval echinococcosis in animals and humans: report of a workshop. Z Parasitenkd. 1982;67(1):5–26. doi: 10.1007/BF00929509. [DOI] [PubMed] [Google Scholar]
  47. Singcharoen T., Mahanonda N., Powell L. W., Baddeley H. Sonographic changes of hydatid cyst of the liver after treatment with mebendazole and albendazole. Br J Radiol. 1985 Sep;58(693):905–907. doi: 10.1259/0007-1285-58-693-905. [DOI] [PubMed] [Google Scholar]
  48. Smyth J. D., Barrett N. J. Procedures for testing the viability of human hydatid cysts following surgical removal, especially after chemotherapy. Trans R Soc Trop Med Hyg. 1980;74(5):649–652. doi: 10.1016/0035-9203(80)90157-1. [DOI] [PubMed] [Google Scholar]
  49. Taylor D. H., Morris D. L., Richards K. S. Albendazole is effective against established Echinococcus granulosus in gerbils: comparison of serum concentrations achieved by gavage and feed administration. Ann Trop Med Parasitol. 1989 Oct;83(5):485–488. doi: 10.1080/00034983.1989.11812376. [DOI] [PubMed] [Google Scholar]
  50. Taylor D. H., Morris D. L., Richards K. S., Reffin D. Echinococcus multilocularis: in vivo results of therapy with albendazole and praziquantel. Trans R Soc Trop Med Hyg. 1988;82(4):611–615. doi: 10.1016/0035-9203(88)90528-7. [DOI] [PubMed] [Google Scholar]
  51. Todorov T., Mechkov G., Vutova K., Georgiev P., Lazarova I., Tonchev Z., Nedelkov G. Factors influencing the response to chemotherapy in human cystic echinococcosis. Bull World Health Organ. 1992;70(3):347–358. [PMC free article] [PubMed] [Google Scholar]
  52. Todorov T., Vutova K., Petkov D., Mechkov G., Kolev K. Albendazole treatment of human cystic echinococcosis. Trans R Soc Trop Med Hyg. 1988;82(3):453–459. doi: 10.1016/0035-9203(88)90161-7. [DOI] [PubMed] [Google Scholar]
  53. Vanparijs O. Chemotherapy of experimental Echinococcus multilocularis in jirds. Parasitol Res. 1990;76(3):238–240. doi: 10.1007/BF00930820. [DOI] [PubMed] [Google Scholar]
  54. Vuitton D. Alveolar echinococcosis of the liver: a parasitic disease in search of a treatment. Hepatology. 1990 Sep;12(3 Pt 1):617–618. doi: 10.1002/hep.1840120329. [DOI] [PubMed] [Google Scholar]
  55. Wen H., Tian W. L., Zou P. F., Xiang M. X. A rare case of mixed cystic and alveolar hydatidosis. Trans R Soc Trop Med Hyg. 1992 May-Jun;86(3):290–291. doi: 10.1016/0035-9203(92)90314-3. [DOI] [PubMed] [Google Scholar]
  56. Wilson J. F., Rausch R. L., McMahon B. J., Schantz P. M., Trujillo D. E., O'Gorman M. A. Albendazole therapy in alveolar hydatid disease: a report of favorable results in two patients after short-term therapy. Am J Trop Med Hyg. 1987 Jul;37(1):162–168. doi: 10.4269/ajtmh.1987.37.162. [DOI] [PubMed] [Google Scholar]
  57. Woodtli W., Bircher J., Witassek F., Eckert J., Wüthrich B., Ammann R. W. Effect of plasma mebendazole concentrations in the treatment of human echinococcosis. Am J Trop Med Hyg. 1985 Jul;34(4):754–760. doi: 10.4269/ajtmh.1985.34.754. [DOI] [PubMed] [Google Scholar]
  58. Yao B. L., Fu L. M., Xu D. Z., Li J., Ding S. X., Tsai S. L. [Clinical manifestations and treatment of 43 cases with liver alveolar hydatid disease in Xinjiang uygur autonomous region]. Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1985;3(4):298–300. [PubMed] [Google Scholar]
  59. Yao P. L. Liver alveolar hydatidosis in the Xinjiang autonomous region. World J Surg. 1983 Jul;7(4):511–518. doi: 10.1007/BF01655942. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES